Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Institute Of Hematology And Blood Transfusion, Czech Republic

Clinical trials sponsored by Institute Of Hematology And Blood Transfusion, Czech Republic, explained in plain language.

Trials to join now! 1

Engineered immune cells take aim at stubborn blood cancers in early trial

Disease control Recruiting now

This early-phase trial tests a personalized cell therapy called CART123 for adults with certain blood cancers (like acute myeloid leukemia) that have not responded to standard treatments. Each patient's own immune cells are collected, modified to target a protein called CD123 on …

Phase: EARLY_PHASE1 • Sponsor: Institute of Hematology and Blood Transfusion, Czech Republic • Aim: Disease control

Last updated May 02, 2026 20:44 UTC